The India Semaglutide market is estimated to be valued at USD 1.39 Bn in 2026 and is expected to reach USD 3.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.7% from 2026 to 2032
As per an article published by NLM in February 2023, the diabetes prevalence in the country for adults aged between 20 and 79 years is predicted to increase from 8.2% to 9.7% by the end of 2030
Glycine: A conditionally essential amino acid that supports metabolic function, anti-inflammatory pathways, and tissue repair
and M.C
This medications effectivenessmay diminish over time, and its approved for use for only 12 weeks
however, these findings need to be further validated in randomised controlled trials, lead study author Markku Lhteenvuo, MD, PhD, of the University of Eastern Finland and the Niuvanniemi Hospital, in a statement